Quantum Biopharma Ltd. | WebDisclosure

Basculer en Français

10163	Companies
208785	Keywords
138903	Articles
110671	Press releases

Headlines Articles Press releases Quantum Biopharma Ltd.

Home
Companies
Quantum Biopharma Ltd.

PRESS RELEASE

published on 12/20/2024 at 15:15, 1 year 3 months ago

Quantum Biopharma Diversifies Treasury With the Purchase of USD $1,000,000 of Bitcoin (BTC) and Other Cryptocurrencies and to Allow for Future Financings and Other Transactions in Cryptocurrency
Quantum BioPharma Ltd. purchases $1,000,000 Bitcoin and other cryptocurrencies, allows cryptocurrency transactions, emphasizing compliance and potential returns for shareholders

Bitcoin Compliance Investment Cryptocurrency Quantum BioPharma
BRIEF

published on 12/14/2024 at 01:05, 1 year 3 months ago

Quantum BioPharma conclut la première tranche de son offre

Première Tranche Biopharmacie Quantique Unités D'obligations Développement Du Capital Dollars Canadiens
BRIEF

published on 12/14/2024 at 01:05, 1 year 3 months ago

Quantum BioPharma Concludes Initial Tranche of Offering

First Tranche Capital Development Quantum BioPharma Canadian Dollars Debenture Units
PRESS RELEASE

published on 12/14/2024 at 01:00, 1 year 3 months ago

Quantum Biopharma Announces Closing of First Tranche
Quantum BioPharma closes initial tranche of offering, issuing 500 Debenture Units for $500,000. Proceeds for business development and working capital. Securities subject to statutory hold period

Working Capital Statutory Hold Period Quantum BioPharma Debenture Units Tranche Offering
BRIEF

published on 12/10/2024 at 13:35, 1 year 3 months ago

Quantum Biopharma avance dans l'essai clinique Lucid-MS

Recherche Biopharmaceutique Biopharmacie Quantique Examen De Sécurité Essai Lucid-MS Progrès Clinique
BRIEF

published on 12/10/2024 at 13:35, 1 year 3 months ago

Quantum Biopharma Moves Forward in Lucid-MS Clinical Trial

Biopharmaceutical Research Quantum BioPharma Lucid-MS Trial Clinical Advancement Safety Review
PRESS RELEASE

published on 12/10/2024 at 13:30, 1 year 3 months ago

Quantum Biopharma Announces That the Safety Review Committee Recommends Commencing Dosing of Second Cohort in the Phase 1 Multiple Ascending Dose Clinical Trial for Lucid-21-302 (Lucid-MS)
Quantum BioPharma announces approval to proceed with dosing of second cohort in Lucid-21-302 trial. Company focused on innovative treatments for neurodegenerative disorders

Drug Development Neurodegenerative Disorders Quantum BioPharma Lucid-21-302 Trial Safety Review Committee
BRIEF

published on 12/05/2024 at 13:35, 1 year 4 months ago

Quantum BioPharma Launches Private Placement for $5 Million

Private Placement Convertible Debenture Canadian Market Investment Offering Quantum BioPharma
BRIEF

published on 12/05/2024 at 13:35, 1 year 4 months ago

Quantum BioPharma lance un placement privé de 5 millions de dollars

Placement Privé Marché Canadien Obligation Convertible Biopharmacie Quantique Offre D'investissement
PRESS RELEASE

published on 12/05/2024 at 13:30, 1 year 4 months ago

Quantum Biopharma Announces Non-Brokered Private Placement of Convertible Debenture Units for Gross Proceeds of Up to $5 Million
Quantum BioPharma announces a non-brokered private placement offering of convertible debenture units. Proceeds for business development and working capital

Private Placement Working Capital Business Development Quantum BioPharma Debenture Units

Accesswire

Published on 04/06/2026 at 15:15, 6 hours 46 minutes ago

Datavault AI CEO Nathaniel T. Bradley to Deliver Flagship Keynotes on Breakthrough RWA Tokenization at CONV3RGENCE London and AssetRush × Zurich 2026
Published on 04/06/2026 at 14:55, 7 hours 6 minutes ago

Hillcrest Closes Shares for Debt Offering
Published on 04/06/2026 at 14:02, 7 hours 59 minutes ago

Black Iron annonce un placement privé d’unités pour un produit brut pouvant atteindre 1,7 million de dollars américains
Published on 04/06/2026 at 13:15, 8 hours 46 minutes ago

Avino Announces Normal Course Issuer Bid for Common Shares
Published on 04/06/2026 at 13:00, 9 hours 1 minute ago

Revolve Signs Interconnection Agreement for 130 MW EL 24 Wind Project in Mexico

View all ACCESSWIRE

EQS Group

Published on 04/06/2026 at 19:00, 3 hours 1 minute ago

PATRIMOINE ET COMMERCE: Déclaration des transactions sur actions propres (Hors contrat de liquidité) réalisées du 30 MARS 2026 au 03 AVRIL 2026
Published on 04/06/2026 at 15:50, 6 hours 11 minutes ago

Mesabi Metallics Secures $150 Million from Macquarie Group
Published on 04/06/2026 at 15:24, 6 hours 36 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Schroders plc
Published on 04/06/2026 at 15:23, 6 hours 38 minutes ago

Form 8.3 - The Vanguard Group, Inc.: British Land Company plc, The
Published on 04/06/2026 at 15:21, 6 hours 39 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Beazley plc

Les Echos

Published on 04/06/2026 at 15:00, 7 hours 1 minute ago

FinanceWire Introduces Certidox to Enable Verifiable Press Releases as Fake Content Becomes Indistinguishable from Reality
Published on 04/06/2026 at 15:00, 7 hours 1 minute ago

FinanceWire intègre Certidox pour permettre la vérification des communiqués de presse, alors que les contenus falsifiés deviennent impossibles à distinguer de la réalité
Published on 04/03/2026 at 18:46, 3 days 3 hours ago

Disclosure of Share Capital and Voting Rights as of March 31, 2026
Published on 04/03/2026 at 18:46, 3 days 3 hours ago

Déclaration du nombre d’actions et droits de vote au 31 mars 2026
Published on 04/03/2026 at 18:01, 3 days 3 hours ago

ALTAREIT : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL

View all LES ECHOS COMFI WIRE